AU2018901673A0 - Peptide Activating Agent - Google Patents
Peptide Activating AgentInfo
- Publication number
- AU2018901673A0 AU2018901673A0 AU2018901673A AU2018901673A AU2018901673A0 AU 2018901673 A0 AU2018901673 A0 AU 2018901673A0 AU 2018901673 A AU2018901673 A AU 2018901673A AU 2018901673 A AU2018901673 A AU 2018901673A AU 2018901673 A0 AU2018901673 A0 AU 2018901673A0
- Authority
- AU
- Australia
- Prior art keywords
- activating agent
- peptide activating
- peptide
- agent
- activating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201980046742.9A CN112399970B (en) | 2018-05-15 | 2019-05-15 | peptide activator |
| JP2021514457A JP7386852B2 (en) | 2018-05-15 | 2019-05-15 | Peptide activator |
| CA3100074A CA3100074A1 (en) | 2018-05-15 | 2019-05-15 | Peptide activating agent |
| PCT/AU2019/050463 WO2019218016A1 (en) | 2018-05-15 | 2019-05-15 | Peptide activating agent |
| KR1020207036029A KR20210021984A (en) | 2018-05-15 | 2019-05-15 | Peptide Activation Agent |
| AU2019268412A AU2019268412B2 (en) | 2018-05-15 | 2019-05-15 | Peptide activating agent |
| US17/055,274 US11912789B2 (en) | 2018-05-15 | 2019-05-15 | Peptide activating agent |
| EP19803268.2A EP3794014A4 (en) | 2018-05-15 | 2019-05-15 | PEPTIDE ENHANCING AGENT |
| US18/414,738 US20250019397A1 (en) | 2018-05-15 | 2024-01-17 | Peptide Activating Agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2018901673A0 true AU2018901673A0 (en) | 2018-05-31 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3619238A4 (en) | Cytotoxicity-inducing therapeutic agent | |
| EP3735463A4 (en) | Cytotoxicity-inducing therapeutic agent | |
| EP3653063A4 (en) | Peptide | |
| EP3882263A4 (en) | Glucagon-derived peptide and use thereof | |
| EP3794015A4 (en) | Activating agents | |
| AU2019350356A1 (en) | Arginase1 polypeptides | |
| EP4039328A4 (en) | Dysuria-alleviating agent | |
| EP3834079A4 (en) | Multi-question multi-answer configuration | |
| EP3995506A4 (en) | Norovirus-binding peptide | |
| EP3978511A4 (en) | Norovirus-binding peptide | |
| EP3881838A4 (en) | Bonding agent | |
| AU2018901673A0 (en) | Peptide Activating Agent | |
| HK40116853A (en) | Mitochondria-targeting peptides | |
| HK40107199A (en) | Mitochondria-targeting peptides | |
| HK40119599A (en) | An isolated peptide | |
| HK40063723B (en) | Dna-cutting agent | |
| HK40066134A (en) | Dna-cutting agent | |
| AU2017901654A0 (en) | Peptide Activating Agent | |
| HK40061702A (en) | Mitochondria-targeting peptides | |
| HK40077506A (en) | Q-er peptide | |
| HK40046560A (en) | Peptide compounds | |
| HK40074738A (en) | Melanocyte-regulating peptides | |
| AU2018901672A0 (en) | Activating Agents | |
| EP3881839A4 (en) | Bonding agent | |
| HK40041704A (en) | Peptides and uses thereof |